Induction with Rabbit Antithymocyte Globulin versus Induction with Corticosteroids in Liver Transplantation: Impact on Recurrent Hepatitis C Virus Infection
Authors:
- Satheesh NairSNSatheesh Nair
- George E. LossGLGeorge E. Loss
- Ari J. CohenACAri J. Cohen
- James D. EasonJEJames D. Eason
- 1 February 2006
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 81 (4) , 620-622
Abstract
This study compares the clinical course of recurrent hepatitis C virus (HCV) infection between 64 patients, who were randomized to receive either rabbit antithymocyte globulin (RATG) or steroids as induction therapy with tacrolimus for maintenance. The HCV recurrence was assessed by HCV RNA levels, peak ALT at 3-6 months, the grade of inflammation at biopsy at 3-6 months posttransplant, progression of fibrosis, and survival. All patients had also received antiviral therapy with interferon alpha 2b and ribavirin, if there were no contraindications. There was no statistically significant difference between the two groups in terms of inflammation at 3 months, peak ALT, or HCV RNA. The survival between the two groups of patients was similar. It appears that steroid-free liver transplantation with RATG induction does not have any negative influence on HCV recurrence in hepatitis C patients after liver transplantation.Keywords
This publication has 8 references indexed in Scilit:
- A Model to Predict Severe Hcv–Related Disease Following Liver TransplantationHepatology, 2003
- Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1Transplantation, 2003
- The association between hepatitis C infection and survival after orthotopic liver transplantationGastroenterology, 2002
- Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: Results from a double-blind randomized placebo-controlled trialLiver Transplantation, 2002
- STEROID ELIMINATION 24 HOURS AFTER LIVER TRANSPLANTATION USING DACLIZUMAB, TACROLIMUS, AND MYCOPHENOLATE MOFETIL1Transplantation, 2001
- HCV-related fibrosis progression following liver transplantation: increase in recent yearsJournal of Hepatology, 2000
- Comparison of pharmacokinetics of neoral and sandimmune in stable pediatric liver transplant recipientsLiver Transplantation and Surgery, 1999
- High Incidence of Allograft Cirrhosis in Hepatitis C Virus Genotype 1B Infection Following Transplantation: Relationship With Rejection EpisodesHepatology, 1999